A citation-based method for searching scientific literature

Caitlin E M Thornton, Jingzhu Hao, Prasanna P Tamarapu, Iñigo Landa. Cancers (Basel) 2022
Times Cited: 2







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
338
100


Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
574
100

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas.
Meihua Jin, Dong Eun Song, Jonghwa Ahn, Eyun Song, Yu-Mi Lee, Tae-Yon Sung, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon,[...]. Cancers (Basel) 2021
6
50

RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.
Rozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, Brian P Danysh, Kurt W Evans, Tyler J Moss, Argun Akcakanat, Patrick K S Ng, Christina M Knippler, Jalyn A Golden,[...]. Cancers (Basel) 2021
4
50

Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer.
Caitlin O Caperton, Lee Ann Jolly, Nicole Massoll, Andrew J Bauer, Aime T Franco. Cancers (Basel) 2021
2
50

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
Cesar Seigi Fuziwara, Diego Claro de Mello, Edna Teruko Kimura. Cancers (Basel) 2022
1
100


Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism.
Cinthia Carolina Stempin, Romina Celeste Geysels, Sunmi Park, Luz Maria Palacios, Ximena Volpini, Claudia Cristina Motran, Eva Virginia Acosta Rodríguez, Juan Pablo Nicola, Sheue-Yann Cheng, Claudia Gabriela Pellizas,[...]. Cancers (Basel) 2021
6
50

APOBEC SBS13 Mutational Signature-A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma.
Sarah Siraj, Tariq Masoodi, Abdul K Siraj, Saud Azam, Zeeshan Qadri, Sandeep K Parvathareddy, Rong Bu, Khawar S Siddiqui, Saif S Al-Sobhi, Mohammed AlDawish,[...]. Cancers (Basel) 2022
2
50

MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression.
Danny Misiak, Marcus Bauer, Jana Lange, Jacob Haase, Juliane Braun, Kerstin Lorenz, Claudia Wickenhauser, Stefan Hüttelmaier. Cancers (Basel) 2021
2
50


Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes.
Miriam Steinschneider, Jacob Pitaro, Shlomit Koren, Yuval Mizrakli, Carlos Benbassat, Limor Muallem Kalmovich. Cancers (Basel) 2021
4
50

Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples.
Emanuela Minna, Paola Romeo, Matteo Dugo, Loris De Cecco, Antonella Aiello, Federico Pistore, Andrea Carenzo, Angela Greco, Maria Grazia Borrello. Cancers (Basel) 2022
2
50

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
431
50

Radio-Iodide Treatment: From Molecular Aspects to the Clinical View.
Antonio De la Vieja, Garcilaso Riesco-Eizaguirre. Cancers (Basel) 2021
11
50

Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up.
Abdul K Siraj, Sandeep Kumar Parvathareddy, Zeeshan Qadri, Khawar Siddiqui, Saif S Al-Sobhi, Fouad Al-Dayel, Khawla S Al-Kuraya. Cancers (Basel) 2020
9
50

Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas.
Thaise Nayane Ribeiro Carneiro, Larissa Valdemarin Bim, Vanessa Candiotti Buzatto, Vanessa Galdeno, Paula Fontes Asprino, Eunjung Alice Lee, Pedro Alexandre Favoretto Galante, Janete Maria Cerutti. Cancers (Basel) 2021
2
50


Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma.
Antónia Afonso Póvoa, Elisabete Teixeira, Maria Rosa Bella-Cueto, Rui Batista, Ana Pestana, Miguel Melo, Thalita Alves, Mafalda Pinto, Manuel Sobrinho-Simões, Jorge Maciel,[...]. Cancers (Basel) 2021
4
50

Translational Utility of Liquid Biopsies in Thyroid Cancer Management.
Ayanthi A Wijewardene, Marthe Chehade, Matti L Gild, Roderick J Clifton-Bligh, Martyn Bullock. Cancers (Basel) 2021
2
50

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park,[...]. Cancer 2016
103
50



An Activity Switch in Human Telomerase Based on RNA Conformation and Shaped by TCAB1.
Lu Chen, Caitlin M Roake, Adam Freund, Pedro J Batista, Siqi Tian, Yi A Yin, Chandresh R Gajera, Shengda Lin, Byron Lee, Matthew F Pech,[...]. Cell 2018
39
50

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
171
50

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
203
50

Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer.
Wanil Kim, Andrew T Ludlow, Jaewon Min, Jerome D Robin, Guido Stadler, Ilgen Mender, Tsung-Po Lai, Ning Zhang, Woodring E Wright, Jerry W Shay. PLoS Biol 2016
103
50

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
78
50

Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers.
Cristina Montero-Conde, Luis Javier Leandro-García, Ángel M Martínez-Montes, Paula Martínez, Francisco J Moya, Rocío Letón, Eduardo Gil, Natalia Martínez-Puente, Sonsoles Guadalix, Maria Currás-Freixes,[...]. Clin Transl Med 2022
2
50

Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels.
X Yi, V M Tesmer, I Savre-Train, J W Shay, W E Wright. Mol Cell Biol 1999
121
50

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
433
50

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Martin Hysek, Johan O Paulsson, Kenbugul Jatta, Ivan Shabo, Adam Stenman, Anders Höög, Catharina Larsson, Jan Zedenius, Carl Christofer Juhlin. Cancers (Basel) 2019
22
50

Telomere-related Markers for Cancer.
Xiaotian Yuan, Mingkai Dai, Dawei Xu. Curr Top Med Chem 2020
19
50

Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours.
Ana Pestana, Rui Batista, Ricardo Celestino, Sule Canberk, Manuel Sobrinho-Simões, Paula Soares. Cancers (Basel) 2020
6
50



Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features.
Xiangling Xing, Ninni Mu, Xiaotian Yuan, Na Wang, C Christofer Juhlin, Klas Strååt, Catharina Larsson, Shi Yong Neo, Dawei Xu. Cancers (Basel) 2022
2
50

Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Zubair W Baloch, Sylvia L Asa, Justine A Barletta, Ronald A Ghossein, C Christofer Juhlin, Chan Kwon Jung, Virginia A LiVolsi, Mauro G Papotti, Manuel Sobrinho-Simões, Giovanni Tallini,[...]. Endocr Pathol 2022
48
50

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, Tomoe Nakao, Kosho Yamanouchi, Chika Sakimura, Hiroshi Yano, Eijun Nishihara, Mitsuyoshi Hirokawa, Keiji Suzuki,[...]. Thyroid 2019
27
50

Telomerase core components protect Candida telomeres from aberrant overhang accumulation.
Min Hsu, Michael J McEachern, Alain T Dandjinou, Yehuda Tzfati, Erica Orr, Elizabeth H Blackburn, Neal F Lue. Proc Natl Acad Sci U S A 2007
27
50

TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Ebtesam Qasem, Avaniyapuram Kannan Murugan, Hindi Al-Hindi, Mingzhao Xing, Mai Almohanna, Meshael Alswailem, Ali S Alzahrani. Endocr Relat Cancer 2015
35
50

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
398
50

Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress.
Shaheda Ahmed, João F Passos, Matthew J Birket, Tina Beckmann, Sebastian Brings, Heiko Peters, Mark A Birch-Machin, Thomas von Zglinicki, Gabriele Saretzki. J Cell Sci 2008
308
50


TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
Martin Hysek, Johan O Paulsson, Na Wang, Kenbugul Jatta, Claes Lindh, Nelson Fuentes-Martinez, Ivan Shabo, Jan Zedenius, C Christofer Juhlin. Virchows Arch 2018
13
50

Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Seung Eun Lee, Tae Sook Hwang, Yoon-La Choi, Hye Seung Han, Wan Seop Kim, Min Hye Jang, Suk Kyeong Kim, Jung Hyun Yang. Thyroid 2016
48
50

Preoperative Assessment of TERT Promoter Mutation on Thyroid Core Needle Biopsies Supports Diagnosis of Malignancy and Addresses Surgical Strategy.
A Crescenzi, P Trimboli, D C Modica, C Taffon, L Guidobaldi, S Taccogna, A Rainer, M Trombetta, E Papini, G Zelano. Horm Metab Res 2016
25
50

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
297
50

Telomerase Regulation: A Role for Epigenetics.
Fatma Dogan, Nicholas R Forsyth. Cancers (Basel) 2021
16
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.